2 Matching Annotations
  1. Aug 2022
  2. www.medrxiv.org www.medrxiv.org
    Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
    1
    1. jackiekrauss 29 Aug 2022

      Sadoff, J., Gars, M. L., Cardenas, V., Shukarev, G., Vaissiere, N., Heerwegh, D., Truyers, C., Groot, A. M. de, Scheper, G., Hendriks, J., Ruiz-Guinazu, J., Struyf, F., Hoof, J. V., Douoguih, M., & Schuitemaker, H. (2021). Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting (p. 2021.08.25.21262569). https://doi.org/10.1101/2021.08.25.21262569

      is:article lang:en COVID-19 antibody response durability booster Johnson & Johnson vaccine initial immunization immune memory Ad26.COV2.S
    Visit annotations in context

    Tags

    Annotators

    URL

    medrxiv.org/cgi/content/10.1101/2021.08.25.21262569
  3. Jul 2021
  4. www.nejm.org www.nejm.org
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination | NEJM
    1
    1. Lu17Cheryl 29 Jul 2021

      Barouch, Dan H., Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, et al. “Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.” New England Journal of Medicine 0, no. 0 (July 14, 2021): null. https://doi.org/10.1056/NEJMc2108829.

      is:article lang:en COVID-19 Coronavirus pandemic immunity vaccine Johnson & Johnson-Janssen cellular immune response Ad26.COV2.S vaccine antibody Delta variant T-cell response acute respiratory syndrome SARS-CoV-2 SARS-CoV-2 variant
    Visit annotations in context

    Tags

    Annotators

    URL

    nejm.org/doi/full/10.1056/NEJMc2108829